Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 26 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 10 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 10, 2019 Filed Jul 12, 2019 20:18 UTC |
Hill Scott AChief Financial Officer
|
SaleCommon Stock | 33,875 | $90.06 | $3,050,782.50 |
DisclosureSEC source: 0001209191-19-041929 · doc4.xml · nonDerivative · entry 2 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,920 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $90.00 - $90.12. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 112,767 shares of common stock and 34,153 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 20:18 UTC |
Hill Scott AChief Financial Officer
|
Exercise / conversionCommon Stock | 26,375 | $22.43 | $591,591.25 |
DisclosureSEC source: 0001209191-19-041929 · doc4.xml · nonDerivative · entry 1 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: Amount of securities beneficially owned includes 165 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 28, 2019. Read SEC document |
| July 05, 2019 Filed Jul 8, 2019 20:20 UTC |
Goone David SChief Strategic Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 4,450 | $0.00 Strike: $22.43 | $0.00 |
DisclosureSEC source: 0001209191-19-041407 · doc4.xml · derivative · entry 3 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,450 shares Expires 2022-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested. Read SEC document |
| July 05, 2019 Filed Jul 8, 2019 20:20 UTC |
Goone David SChief Strategic Officer
|
SaleCommon Stock | 9,405 | $89.01 | $837,131.53 |
DisclosureSEC source: 0001209191-19-041407 · doc4.xml · nonDerivative · entry 2 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,740 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $89.00 - $89.06. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 134,705 shares of common stock and 28,035 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting. Read SEC document |
| July 05, 2019 Filed Jul 8, 2019 20:20 UTC |
Goone David SChief Strategic Officer
|
Exercise / conversionCommon Stock | 4,450 | $22.43 | $99,813.50 |
DisclosureSEC source: 0001209191-19-041407 · doc4.xml · nonDerivative · entry 1 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 17:29 UTC |
Vice Charles AVice Chairman
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 15,000 | $0.00 Strike: $57.31 | $0.00 |
DisclosureSEC source: 0001209191-19-040783 · doc4.xml · derivative · entry 4 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,412 Underlying: Common Stock · 15,000 shares Expires 2027-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options are fully vested. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 17:29 UTC |
Vice Charles AVice Chairman
|
SaleCommon Stock | 128 | $87.29 | $11,173.12 |
DisclosureSEC source: 0001209191-19-040783 · doc4.xml · nonDerivative · entry 3 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 406,936 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 358,510 shares of common stock and 48,426 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 17:29 UTC |
Vice Charles AVice Chairman
|
SaleCommon Stock | 14,872 | $86.74 | $1,289,992.82 |
DisclosureSEC source: 0001209191-19-040783 · doc4.xml · nonDerivative · entry 2 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 407,064 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $86.275 - $87.24. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 17:29 UTC |
Vice Charles AVice Chairman
|
Exercise / conversionCommon Stock | 15,000 | $57.31 | $859,650.00 |
DisclosureSEC source: 0001209191-19-040783 · doc4.xml · nonDerivative · entry 1 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 421,936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: Amount of securities beneficially owned includes 165 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 28, 2019. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 20:20 UTC |
Martin Lynn CPresident & COO, ICE Data Serv
|
SaleCommon Stock | 135 | $85.10 | $11,488.50 |
DisclosureSEC source: 0001209191-19-035538 · doc4.xml · nonDerivative · entry 2 Martin Lynn C · CIK 0001754817 · President & COO, ICE Data Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,360 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 14,813 shares of common stock and 13,547 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 20:19 UTC |
Jackson BenjaminPresident
|
SaleCommon Stock | 2,075 | $85.00 | $176,381.43 |
DisclosureSEC source: 0001209191-19-035536 · doc4.xml · nonDerivative · entry 2 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,449 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $85.00 - $85.02. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 44,938 shares of common stock, 2,838 unvested restricted stock units ("RSUs"), and 23,673 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and the PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 PSUs tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 20:19 UTC |
Hill Scott AChief Financial Officer
|
SaleCommon Stock | 4,247 | $85.01 | $361,023.88 |
DisclosureSEC source: 0001209191-19-035535 · doc4.xml · nonDerivative · entry 2 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,255 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $85.00 - $85.06. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 120,102 shares of common stock and 34,153 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting. Read SEC document |
| June 05, 2019 Filed Jun 6, 2019 20:22 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 1,000 | $85.00 | $85,000.00 |
DisclosureSEC source: 0001209191-19-035065 · doc4.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,861 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 33,744 shares of common stock and 6,117 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 20:20 UTC |
Martin Lynn CPresident & COO, ICE Data Serv
|
SaleCommon Stock | 2,365 | $85.00 | $201,025.00 |
DisclosureSEC source: 0001209191-19-035538 · doc4.xml · nonDerivative · entry 1 Martin Lynn C · CIK 0001754817 · President & COO, ICE Data Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,495 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 20:19 UTC |
Jackson BenjaminPresident
|
SaleCommon Stock | 2,925 | $85.00 | $248,625.59 |
DisclosureSEC source: 0001209191-19-035536 · doc4.xml · nonDerivative · entry 1 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,524 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $85.00 - $85.01. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 20:19 UTC |
Hill Scott AChief Financial Officer
|
SaleCommon Stock | 3,253 | $85.00 | $276,505.00 |
DisclosureSEC source: 0001209191-19-035535 · doc4.xml · nonDerivative · entry 1 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,502 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 20:32 UTC |
Vice Charles AVice Chairman
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 20,000 | $0.00 Strike: $57.31 | $0.00 |
DisclosureSEC source: 0001209191-19-034287 · doc4.xml · derivative · entry 3 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,412 Underlying: Common Stock · 20,000 shares Expires 2027-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 20:32 UTC |
Vice Charles AVice Chairman
|
SaleCommon Stock | 20,000 | $82.29 | $1,645,846.00 |
DisclosureSEC source: 0001209191-19-034287 · doc4.xml · nonDerivative · entry 2 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 406,771 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $81.955 - $82.62. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 358,345 shares of common stock and 48,426 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 20:32 UTC |
Vice Charles AVice Chairman
|
Exercise / conversionCommon Stock | 20,000 | $57.31 | $1,146,200.00 |
DisclosureSEC source: 0001209191-19-034287 · doc4.xml · nonDerivative · entry 1 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| May 29, 2019 Filed May 30, 2019 20:24 UTC |
TESE VINCENTDirector
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-033430 · doc4.xml · nonDerivative · entry 2 TESE VINCENT · CIK 0001042445 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,004 F2 · shares: This transaction involved a gift of 1,000 shares of the Issuer's common stock by the reporting person to a philanthropic organization. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 31,420 shares of common stock and 2,584 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020. Read SEC document |
| May 29, 2019 Filed May 30, 2019 20:24 UTC |
TESE VINCENTDirector
|
SaleCommon Stock | 2,000 | $81.87 | $163,739.20 |
DisclosureSEC source: 0001209191-19-033430 · doc4.xml · nonDerivative · entry 1 TESE VINCENT · CIK 0001042445 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,004 F1 · price: The price range for the aggregate amount sold by the direct holder is $81.86 - $81.89. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| May 23, 2019 Filed May 28, 2019 20:26 UTC |
CRISP CHARLES RDirector
|
SaleCommon Stock | 2,445 | $81.10 | $198,279.72 |
DisclosureSEC source: 0001209191-19-032987 · doc4.xml · nonDerivative · entry 1 CRISP CHARLES R · CIK 0001015825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,152 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $80.74 - $81.34. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 50,875 shares of common stock and 2,445 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020. Read SEC document |
| May 23, 2019 Filed May 28, 2019 20:27 UTC |
Hague William JeffersonDirector
|
SaleCommon Stock | 839 | $81.14 | $68,077.47 |
DisclosureSEC source: 0001209191-19-032992 · doc4.xml · nonDerivative · entry 1 Hague William Jefferson · CIK 0001652762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,104 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $80.79 - $81.44. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 9,520 shares of common stock and 2,584 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020. Read SEC document |
| May 23, 2019 Filed May 28, 2019 20:28 UTC |
SPRIESER JUDITH ADirector
|
SaleCommon Stock | 2,794 | $81.04 | $226,418.22 |
DisclosureSEC source: 0001209191-19-032996 · doc4.xml · nonDerivative · entry 1 SPRIESER JUDITH A · CIK 0001206994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,064 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $80.74 - $81.34. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 24,480 shares of common stock and 2,584 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020. Read SEC document |
| May 23, 2019 Filed May 28, 2019 20:28 UTC |
Hatfield Fred WDirector
|
SaleCommon Stock | 2,794 | $81.09 | $226,562.95 |
DisclosureSEC source: 0001209191-19-032993 · doc4.xml · nonDerivative · entry 1 Hatfield Fred W · CIK 0001399286 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,065 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $80.74 - $81.31. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 31,481 shares of common stock and 2,584 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020. Read SEC document |
| May 23, 2019 Filed May 28, 2019 20:26 UTC |
Forneri Jean MarcDirector
|
SaleCommon Stock | 1,222 | $81.10 | $99,099.80 |
DisclosureSEC source: 0001209191-19-032990 · doc4.xml · nonDerivative · entry 1 Forneri Jean Marc · CIK 0001343872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,800 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $80.77 - $81.42. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 20,523 shares of common stock and 2,277 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020. Read SEC document |
| May 22, 2019 Filed May 23, 2019 20:24 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 2,285 | $81.26 | $185,675.90 |
DisclosureSEC source: 0001209191-19-032297 · doc4.xml · nonDerivative · entry 3 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 111,092 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F7 · price: The price range for the aggregate amount sold by the direct holder is $81.07 - $81.58. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F8 · balance_after: The common stock number referred in Table I is an aggregate number and represents 99,869 shares of common stock, 7,733 unvested restricted stock units ("RSUs"), and and 3,490 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2017 and 2018 total shareholder return PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and February 2021, respectively, and will be reported at the time of vesting. F9 · balance_after: As previously reported, the reporting person also indirectly owns 3,671,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person also beneficially owns shares directly. Read SEC document |
| May 22, 2019 Filed May 23, 2019 20:24 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 20,000 | $81.26 | $1,625,276.00 |
DisclosureSEC source: 0001209191-19-032297 · doc4.xml · nonDerivative · entry 2 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · CPEX Disclosed balance after: 3,671,705 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F5 · price: The price range for the aggregate amount sold by the direct holder is $81.04 - $81.70. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F6 · balance_after: These shares are beneficially owned directly by CPEX. Mr. Sprecher beneficially owns 100% of the equity interest in CPEX directly. Additionally, as previously reported, the reporting person also owns shares directly and indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership. Read SEC document |
| May 22, 2019 Filed May 23, 2019 20:24 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 30,881 | $81.26 | $2,509,482.70 |
DisclosureSEC source: 0001209191-19-032297 · doc4.xml · nonDerivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,475,328 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $81.05 - $81.71. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,365,734 shares of common stock and 109,594 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting. F4 · balance_after: As previously reported, the reporting person also indirectly owns 3,671,705 shares that are beneficially owned directly by Continental Power Exchange, Inc. ("CPEX"). The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership. Read SEC document |
| May 20, 2019 Filed May 22, 2019 20:22 UTC |
Hague William JeffersonDirector
|
Tax withholdingCommon Stock | 193 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032048 · doc4.xml · nonDerivative · entry 1 Hague William Jefferson · CIK 0001652762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,943 F1 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 10,359 shares of common stock and 2,584 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020. Read SEC document |
| May 17, 2019 Filed May 21, 2019 21:18 UTC |
CRISP CHARLES RDirector
|
GrantCommon Stock | 2,277 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031795 · doc4.xml · nonDerivative · entry 1 CRISP CHARLES R · CIK 0001015825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,597 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 53,320 shares of common stock and 2,277 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020. Read SEC document |
| May 17, 2019 Filed May 21, 2019 21:08 UTC |
NOONAN THOMAS EDirector
|
GrantCommon Stock | 2,277 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031790 · doc4.xml · nonDerivative · entry 1 NOONAN THOMAS E · CIK 0001079742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,787 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 8,510 shares of common stock and 2,277 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020. Read SEC document |
| May 17, 2019 Filed May 21, 2019 21:20 UTC |
TESE VINCENTDirector
|
GrantCommon Stock | 2,584 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031801 · doc4.xml · nonDerivative · entry 1 TESE VINCENT · CIK 0001042445 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,004 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 2,584 restricted stock units awarded, 2,277 were awarded as compensation for service on the Issuer's board and 307 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Clear Credit LLC. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 34,420 shares of common stock and 2,584 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020. Read SEC document |
| May 17, 2019 Filed May 21, 2019 17:09 UTC |
SALERNO FREDERIC VDirector
|
GrantCommon Stock | 2,277 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031793 · doc4.xml · nonDerivative · entry 1 SALERNO FREDERIC V · CIK 0001180138 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,197 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 10,920 shares of common stock and 2,277 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020. Read SEC document |
| May 17, 2019 Filed May 21, 2019 21:07 UTC |
Farooqui Duriya MDirector
|
GrantCommon Stock | 2,277 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031788 · doc4.xml · nonDerivative · entry 1 Farooqui Duriya M · CIK 0001699994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,672 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 5,395 shares of common stock and 2,277 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020. Read SEC document |
| May 17, 2019 Filed May 21, 2019 21:18 UTC |
Hague William JeffersonDirector
|
GrantCommon Stock | 2,584 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031796 · doc4.xml · nonDerivative · entry 1 Hague William Jefferson · CIK 0001652762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,136 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 2,584 restricted stock units awarded, 2,277 were awarded as compensation for service on the Issuer's board and 307 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Futures Europe. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 10,552 shares of common stock and 2,584 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020. Read SEC document |
| May 17, 2019 Filed May 21, 2019 21:19 UTC |
SPRIESER JUDITH ADirector
|
GrantCommon Stock | 2,584 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031800 · doc4.xml · nonDerivative · entry 1 SPRIESER JUDITH A · CIK 0001206994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,858 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 2,584 restricted stock units awarded, 2,277 were awarded as compensation for service on the Issuer's board and 307 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Clear Credit LLC. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 27,274 shares of common stock and 2,584 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020. Read SEC document |
| May 17, 2019 Filed May 21, 2019 21:19 UTC |
Hatfield Fred WDirector
|
GrantCommon Stock | 2,584 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031798 · doc4.xml · nonDerivative · entry 1 Hatfield Fred W · CIK 0001399286 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,859 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 2,584 restricted stock units awarded, 2,277 were awarded as compensation for service on the Issuer's board and 307 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Clear Credit LLC. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 34,275 shares of common stock and 2,584 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020. Read SEC document |
| May 17, 2019 Filed May 21, 2019 21:08 UTC |
Forneri Jean MarcDirector
|
GrantCommon Stock | 2,277 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031789 · doc4.xml · nonDerivative · entry 1 Forneri Jean Marc · CIK 0001343872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,022 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 21,745 shares of common stock and 2,277 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020. Read SEC document |
| May 17, 2019 Filed May 21, 2019 21:06 UTC |
Bowen SharonDirector
|
GrantCommon Stock | 2,277 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031785 · doc4.xml · nonDerivative · entry 1 Bowen Sharon · CIK 0001724974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,189 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 4,912 shares of common stock and 2,277 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 17, 2020. Read SEC document |
| May 08, 2019 Filed May 10, 2019 20:32 UTC |
Jackson BenjaminPresident
|
SaleCommon Stock | 300 | $80.79 | $24,236.01 |
DisclosureSEC source: 0001209191-19-028938 · doc4.xml · nonDerivative · entry 2 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,449 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $80.77 - $80.80. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 49,938 shares of common stock, 2,838 unvested restricted stock units ("RSUs"), and 23,673 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and the PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting. Read SEC document |
| May 08, 2019 Filed May 10, 2019 20:32 UTC |
Jackson BenjaminPresident
|
SaleCommon Stock | 1,155 | $80.42 | $92,880.25 |
DisclosureSEC source: 0001209191-19-028938 · doc4.xml · nonDerivative · entry 1 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,749 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $79.74 - $80.73. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| May 02, 2019 Filed May 3, 2019 20:17 UTC |
Vice Charles AVice Chairman
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 20,000 | $0.00 Strike: $57.31 | $0.00 |
DisclosureSEC source: 0001209191-19-027342 · doc4.xml · derivative · entry 4 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,412 Underlying: Common Stock · 20,000 shares Expires 2027-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options are fully vested. Read SEC document |
| May 02, 2019 Filed May 3, 2019 20:17 UTC |
Vice Charles AVice Chairman
|
SaleCommon Stock | 2,700 | $80.99 | $218,674.08 |
DisclosureSEC source: 0001209191-19-027342 · doc4.xml · nonDerivative · entry 3 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 406,771 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $80.75 - $81.34. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 358,345 shares of common stock and 48,426 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting. Read SEC document |
| May 02, 2019 Filed May 3, 2019 20:17 UTC |
Vice Charles AVice Chairman
|
SaleCommon Stock | 17,300 | $80.28 | $1,388,880.33 |
DisclosureSEC source: 0001209191-19-027342 · doc4.xml · nonDerivative · entry 2 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 409,471 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $79.73 - $80.65. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| May 02, 2019 Filed May 3, 2019 20:17 UTC |
Vice Charles AVice Chairman
|
Exercise / conversionCommon Stock | 20,000 | $57.31 | $1,146,200.00 |
DisclosureSEC source: 0001209191-19-027342 · doc4.xml · nonDerivative · entry 1 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| April 26, 2019 Filed Apr 29, 2019 20:24 UTC |
Surdykowski Andrew JGeneral Counsel
|
GiftCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-026415 · doc4.xml · nonDerivative · entry 2 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,861 F3 · shares: This transaction involved a gift of 300 shares of the Issuer's common stock by the reporting person to a philanthropic organization. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 34,744 shares of common stock and 6,117 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting. Read SEC document |
| April 26, 2019 Filed Apr 29, 2019 20:24 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 1,200 | $81.00 | $97,197.00 |
DisclosureSEC source: 0001209191-19-026415 · doc4.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,161 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $80.77 - $81.09. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| April 17, 2019 Filed Apr 18, 2019 20:01 UTC |
Hill Scott AChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 11,675 | $0.00 Strike: $22.50 | $0.00 |
DisclosureSEC source: 0001209191-19-025231 · doc4.xml · derivative · entry 3 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,675 shares Expires 2021-01-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested. Read SEC document |
| April 17, 2019 Filed Apr 18, 2019 20:01 UTC |
Hill Scott AChief Financial Officer
|
SaleCommon Stock | 11,675 | $80.02 | $934,185.63 |
DisclosureSEC source: 0001209191-19-025231 · doc4.xml · nonDerivative · entry 2 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,755 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $80.00 - $80.10. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 127,602 shares of common stock and 34,153 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.